https://www.selleckchem.com/pr....oducts/5-cholesten-3
31 (CI 1.1-1.7), PWV AG HR 1.24 (CI 1.0-1.5), p less then 0.05, respectively). Increased PWV derived by AG and CMR methods are feasible for MACE prediction in post-infarcted patients. However, adjusted cut-off values of PWV are recommended for different techniques to improve individual risk stratification.The relationship between the in-stent neoatherosclerosis (ISNA) formation and the plaque's characteristic changes in the non-culprit lesion is unclear. We aim to investigate the plaque characteristics changes at non-